• An overview of the current understanding of bleeding and thrombosis in cirrhosis.• An
evidence-based justification for bleeding risk assessment in patients with cirrhosis before …

Splanchnic vein thrombosis (SVT) including portal, mesenteric, splenic vein thrombosis and
the Budd-Chiari syndrome, is a manifestation of unusual site venous thromboembolism. SVT …

Background This is the 2nd update to the 9th edition of these guidelines. We provide
recommendations on 17 PICO (Population, Intervention, Comparator, Outcome) questions …

2.1. 1. Epidemiology and burden of the disease. The annual incidence of first episode of
symptomatic DVT in the adult population ranges from 50 to 100 per 100 000 population, with …

Retinal vein occlusion (RVO) is an obstruction of the retinal venous system by thrombus
formation and may involve the central, hemicentral or branch retinal vein. The most common …

Abstract Purpose of Review The purpose of this update is to summarize the recent advances
on the management of cerebral venous thrombosis (CVT). Recent Findings There is a trend …

Guidelines currently favor vitamin K antagonists or low-molecular-weight heparins for
treatment of noncirrhotic portal vein thrombosis (ncPVT). Use of direct oral anticoagulants …

Portal vein thrombosis (PVT) is a frequent complication in cirrhosis and its prevalence
increases with disease severity. Several factors are involved in the development and …

Retinal vein occlusion represents the second leading cause of retinal vascular disorders,
with a uniform sex distribution worldwide. A thorough evaluation of cardiovascular risk …

Objectives Current guidelines do not recommend direct oral anticoagulants (DOACs) to treat
cerebral venous thrombosis (CVT) despite their benefits over standard therapy. We …